Suppr超能文献

游离型和脂质体包裹型制霉菌素与四种两性霉素B制剂的体外抗真菌活性比较。

Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.

作者信息

Johnson E M, Ojwang J O, Szekely A, Wallace T L, Warnock D W

机构信息

Mycology Reference Laboratory, Public Health Laboratory Service, Bristol, United Kingdom.

出版信息

Antimicrob Agents Chemother. 1998 Jun;42(6):1412-6. doi: 10.1128/AAC.42.6.1412.

Abstract

The in vitro activity of a multilamellar liposomal formulation of nystatin (Nyotran) was compared with those of free nystatin and four pharmaceutical preparations of amphotericin B. MICs for 200 isolates of two Aspergillus spp., seven Candida spp., and Cryptococcus neoformans were determined by a broth microdilution adaptation of the method recommended by the National Committee for Clinical Laboratory Standards. Minimum lethal concentrations (MLCs) of the six antifungal preparations were also determined. Both nystatin formulations possessed fungistatic and fungicidal activities against the 10 species tested. Liposomal nystatin appeared to be as active as free nystatin, with MICs and MLCs that were similar to, or lower than, those of the latter. Neither formulation of nystatin was as active as amphotericin B deoxycholate (Fungizone) or amphotericin B lipid complex (Abelcet), but both were more effective than liposomal amphotericin B (AmBisome). Our results suggest that further evaluation of liposomal nystatin is justified.

摘要

将制霉菌素的多层脂质体制剂(尼可罗)的体外活性与游离制霉菌素以及两性霉素B的四种药物制剂进行了比较。采用美国国家临床实验室标准委员会推荐方法的肉汤微量稀释法,测定了200株两种曲霉菌、七种念珠菌和新型隐球菌的最低抑菌浓度(MIC)。还测定了六种抗真菌制剂的最低致死浓度(MLC)。两种制霉菌素制剂对所测试的10种菌种均具有抑菌和杀菌活性。脂质体制霉菌素似乎与游离制霉菌素活性相当,其MIC和MLC与后者相似或更低。两种制霉菌素制剂的活性均不如两性霉素B脱氧胆酸盐(Fungizone)或两性霉素B脂质复合物(Abelcet),但两者均比脂质体两性霉素B(安必素)更有效。我们的结果表明,对脂质体制霉菌素进行进一步评估是合理的。

相似文献

4
Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.
Eur J Clin Microbiol Infect Dis. 1991 Aug;10(8):665-8. doi: 10.1007/BF01975823.
10
Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformans.
Antimicrob Agents Chemother. 1998 Jul;42(7):1722-5. doi: 10.1128/AAC.42.7.1722.

引用本文的文献

1
Efficacy of Liposomal Nystatin in a Rabbit Model of Cryptococcal Meningitis.
J Fungi (Basel). 2024 Jul 26;10(8):520. doi: 10.3390/jof10080520.
2
Liposomes: An Emerging Strategy for the Effective Treatment of Rheumatoid Arthritis.
Curr Rheumatol Rev. 2025;21(2):123-143. doi: 10.2174/0115733971284274240215064826.
3
Time-kill kinetic of nano-ZnO-loaded nanoliposomes against Aspergillus niger and Botrytis cinerea.
Braz J Microbiol. 2024 Jun;55(2):1669-1678. doi: 10.1007/s42770-024-01273-6. Epub 2024 Feb 19.
4
Lipid-Based Nanotechnology: Liposome.
Pharmaceutics. 2023 Dec 26;16(1):34. doi: 10.3390/pharmaceutics16010034.
5
Water-Soluble Nystatin and Derivative.
ACS Med Chem Lett. 2022 Jan 20;13(2):182-187. doi: 10.1021/acsmedchemlett.1c00538. eCollection 2022 Feb 10.
6
DC-SIGN targets amphotericin B-loaded liposomes to diverse pathogenic fungi.
Fungal Biol Biotechnol. 2021 Dec 24;8(1):22. doi: 10.1186/s40694-021-00126-3.
8
Nystatin Regulates Axonal Extension and Regeneration by Modifying the Levels of Nitric Oxide.
Front Mol Neurosci. 2020 Apr 3;13:56. doi: 10.3389/fnmol.2020.00056. eCollection 2020.
9
Designing Fast-Dissolving Orodispersible Films of Amphotericin B for Oropharyngeal Candidiasis.
Pharmaceutics. 2019 Aug 1;11(8):369. doi: 10.3390/pharmaceutics11080369.

本文引用的文献

3
Fungicidin, an antibiotic produced by a soil actinomycete.
Proc Soc Exp Biol Med. 1951 Jan;76(1):93-7. doi: 10.3181/00379727-76-18397.
4
Nystatin (mycostatin) therapy in experimental coccidioidomycosis.
Am Rev Tuberc. 1955 Jul;72(1):64-70. doi: 10.1164/artpd.1955.72.1.64.
5
Treatment of the deep mycoses.
AMA Arch Intern Med. 1958 Apr;101(4):765-802. doi: 10.1001/archinte.1958.00260160089013.
6
Effect of fungicidin (nystatin) in mice injected with lethal mixtures of aureomycin and Candida albicans.
Science. 1953 May 29;117(3048):609-10. doi: 10.1126/science.117.3048.609.
7
Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.
Antimicrob Agents Chemother. 1997 Oct;41(10):2238-43. doi: 10.1128/AAC.41.10.2238.
9
Lipid formulations of amphotericin B: recent progress and future directions.
Clin Infect Dis. 1996 May;22 Suppl 2:S133-44. doi: 10.1093/clinids/22.supplement_2.s133.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验